Success Metrics

Clinical Success Rate
90.2%

Based on 74 completed trials

Completion Rate
90%(74/82)
Active Trials
3(3%)
Results Posted
41%(30 trials)
Terminated
8(7%)

Phase Distribution

Ph phase_1
14
13%
Ph phase_3
11
10%
Ph early_phase_1
4
4%
Ph phase_2
16
15%
Ph phase_4
32
29%
Ph not_applicable
23
21%

Phase Distribution

18

Early Stage

16

Mid Stage

43

Late Stage

Phase Distribution100 total trials
Early Phase 1First-in-human
4(4.0%)
Phase 1Safety & dosage
14(14.0%)
Phase 2Efficacy & side effects
16(16.0%)
Phase 3Large-scale testing
11(11.0%)
Phase 4Post-market surveillance
32(32.0%)
N/ANon-phased studies
23(23.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.1%

74 of 89 finished

Non-Completion Rate

16.9%

15 ended early

Currently Active

3

trials recruiting

Total Trials

109

all time

Status Distribution
Active(4)
Completed(74)
Terminated(15)
Other(16)

Detailed Status

Completed74
unknown16
Terminated8
Withdrawn7
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
109
Active
3
Success Rate
90.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (4.0%)
Phase 114 (14.0%)
Phase 216 (16.0%)
Phase 311 (11.0%)
Phase 432 (32.0%)
N/A23 (23.0%)

Trials by Status

not_yet_recruiting11%
terminated87%
active_not_recruiting11%
unknown1615%
withdrawn76%
recruiting22%
completed7468%

Recent Activity

Clinical Trials (109)

Showing 20 of 109 trialsScroll for more
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT06192589Phase 1

Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions

Completed
NCT03854578Phase 1

A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions

Completed
NCT06412315Not Applicable

7T Amygdala and Citalopram Study

Recruiting
NCT02473250Phase 4

Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging

Completed
NCT05627154Not Applicable

Combined Antidepressant and Behavioural Intervention

Completed
NCT01032083Phase 4

Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia

Completed
NCT02893371

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated
NCT04975724Phase 4

Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder

Unknown
NCT04476030Phase 3

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder

Completed
NCT06131255

DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")

Not Yet Recruiting
NCT00876226Not Applicable

Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome

Withdrawn
NCT03779789Phase 4

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment

Completed
NCT01742832Phase 2

Double-Blind Treatment of Major Depressive Disorder With Vilazodone

Completed
NCT01667744Phase 1

Citalopram for Sx/Util in Acute Coronary Syndrome Patients

Withdrawn
NCT03516604Phase 1

PF-04995274 and Emotional Processing in Un-medicated Depression

Completed
NCT02022709Phase 4

Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients

Completed
NCT05063604Phase 2

Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

Terminated
NCT04145076Not Applicable

Brain Response to Serotonergic Medications in ASD

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
109